Afrigen gears up to deliver Africa’sfirst Covid-19 mRNA vaccine
On June 25, Reuters reported that Cape Town-based biotechnology company Afrigen Biologics expects a decision in mid-July on partners to produce Africa’s first Covid-19 vaccine using the mRNA platform. The World Health Organisation (WHO) picked Afrigen for a pilot project to give poor and middle-income countries the know-how and licences to make Covid-19.
Afrigen’s managing director, Petro Terblanche said the fastest route would be to go with one of the vaccines that already has market authorisation.
Referring to the instability of mRNA vaccines, which require very cold storage, Terblanche said Afrigen could access technology to produce a “thermostable” mRNA vaccine that could be kept at temperatures of 2-8°C.